//]]>

Antithrombotic Drug Therapy in Cardiovascular Disease (Record no. 19703)

000 -LEADER
fixed length control field 04636nam a22004815i 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140310150646.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100715s2010 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781603272353
978-1-60327-235-3
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC681-688.2
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.12
Edition number 23
264 #1 -
-- Totowa, NJ :
-- Humana Press :
-- Imprint: Humana Press,
-- 2010.
912 ## -
-- ZDB-2-SME
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Askari, Arman T.
Relator term editor.
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE
Title Antithrombotic Drug Therapy in Cardiovascular Disease
Medium [electronic resource] /
Statement of responsibility, etc edited by Arman T. Askari, A. Michael Lincoff.
300 ## - PHYSICAL DESCRIPTION
Extent VIII, 880p. 69 illus., 11 illus. in color.
Other physical details online resource.
440 1# - SERIES STATEMENT/ADDED ENTRY--TITLE
Title Contemporary Cardiology
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Basic Principles -- Platelets in Arterial Thrombosis -- The Role of Coagulation in Arterial and Venous Thrombosis -- The Link Between Inflammation and Thrombosis -- The Genetics of Thrombosis -- Antithrombotic Therapy for Stable Coronary Atherosclerotic Disease -- Aspirin in Primary and Secondary Prevention of Cardiovascular Disease -- Thienopyridines in Stable Coronary Disease -- Antithrombotic Therapy for NSTE ACS -- Antiplatelet Therapies in Unstable Angina and Non-ST Segment Elevation Myocardial Infarction -- Unfractionated Heparin and Enoxaparin for the Management of Non-ST-Segment Elevation Acute Coronary Syndromes -- Direct Thrombin Inhibitors in Acute Coronary Syndromes -- Synthetic Factor Xa Inhibition in Acute Coronary Syndromes -- Antithrombotic Therapy for STEMI -- Antiplatelet Therapies: Aspirin, Clopidogrel and Thienopyridines, and Glycoprotein IIb/IIIa Inhibitors for the Management of ST-Segment Elevation Myocardial Infarction -- Antithrombin Therapy for Acute ST-Segment Elevation Myocardial Infarction -- Fibrinolysis and Facilitated PCI -- Antithrombotic Therapy in Interventional Cardiology -- Antithrombotic Therapy in Percutaneous Coronary Intervention -- Antithrombotic Therapy in Carotid and Peripheral Intervention -- Monitoring of Antithrombotic Therapies in Interventional Cardiology -- Antithrombotic Therapy in Venous Thromboembolism -- Venous Thromboembolism -- Fibrinolysis for Pulmonary Embolism -- Duration of Anticoagulant Therapy After Venous Thromboembolism -- Clinical Consideration -- Antithrombotic Therapy for Atrial Fibrillation and Cardioversion -- Antithrombotic Therapy for Valvular Heart Disease -- Antithrombotic Therapy in Heart Failure and Cardiomyopathy -- Heparin-Induced Thrombocytopenia -- Resistance to Antiplatelet Drugs.
520 ## - SUMMARY, ETC.
Summary, etc Substantial morbidity and mortality remains associated with thrombotic events has stimulated the rapid expansion of the available armamentarium to combat pathologic thrombosis. Pathologic thrombosis plays an essential role in the pathogenesis of acute coronary syndromes (ACS), ischemic complications of percutaneous coronary intervention (PCI), venous thromboembolic disease, and embolic complications of arrhythmias and various cardiomyopathies. Written by experts in the field, Antithrombotic Drug Therapy in Cardiovascular Disease carefully examines individual and various combinations of the available antithrombotic regimens including fibrinolytic agents, antiplatelet therapies (aspirin, thieneopyridines, glycoprotein IIb/IIIa inhibitors), and anticogulant therapies (unfractionated heparin, low-molecular-weight heparins, direct thrombin inhibitors, and synthetic factor X inhibitors), non-ST-segment elevation (NSTE) ACS and ST-segment elevation myocardial infarction (STEMI). A detailed overview, Antithrombotic Drug Therapy in Cardiovascular Disease presents the evidence demonstrating the efficacy of available antithrombotic therapies in specific disease states such as atrial fibrillation, cardiomyopathy, valvular heart disease, and heparin-induced thrombocytopenia (HIT).
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
Topical term or geographic name as entry element Interventional radiology.
Topical term or geographic name as entry element Internal medicine.
Topical term or geographic name as entry element Cardiology.
Topical term or geographic name as entry element Vascular Surgery.
Topical term or geographic name as entry element Medicine & Public Health.
Topical term or geographic name as entry element Cardiology.
Topical term or geographic name as entry element Internal Medicine.
Topical term or geographic name as entry element Interventional Radiology.
Topical term or geographic name as entry element Vascular Surgery.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lincoff, A. Michael.
Relator term editor.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9781603272346
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-1-60327-235-3
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme
Item type E-Book
Copies
Price effective from Permanent location Date last seen Not for loan Date acquired Source of classification or shelving scheme Koha item type Damaged status Lost status Withdrawn status Current location Full call number
2014-04-07AUM Main Library2014-04-07 2014-04-07 E-Book   AUM Main Library616.12

Languages: 
English |
العربية